Skip to Content Skip to Content

Health Sciences

Reset All Filters
2007 Results
Simeprevir-Based Therapy Offers Alternative Treatment of Hepatitis C Says Penn Study

Simeprevir-Based Therapy Offers Alternative Treatment of Hepatitis C Says Penn Study

Researchers at Penn Medicine, in collaboration with a multi-center international team, have shown that a protease inhibitor, simeprevir, a once a day pill, along with interferon and ribavirin has proven as effective in treating chronic Hepatitis C virus infection (HCV) as telaprevir with interferon and ribavirin, the standard of care in developing countries.

Lee-Ann Donegan

Penn Study: Majority of Women with Early-Stage Breast Cancer in U.S. Receive Unnecessarily Long Courses of Radiation

Penn Study: Majority of Women with Early-Stage Breast Cancer in U.S. Receive Unnecessarily Long Courses of Radiation

Two-thirds of women treated for early-stage breast cancer in the U.S. receive longer radiation therapy than necessary, according to a new study published in JAMA this week from Penn Medicineresearchers Ezekiel J. Emanuel, MD, PhD, and Justin E. Bekelman, MD.

Steve Graff

Penn Medicine Researchers Announce Latest Results of Investigational Cellular Therapy CTL019

Penn Medicine Researchers Announce Latest Results of Investigational Cellular Therapy CTL019

The latest results of clinical trials of more than 125 patients testing an investigational personalized cellular therapy known as CTL019 will be presented by a University of Pennsylvania research team at the 56th American Society of Hematology Annual Meeting and Exposition.

Holly Auer

Penn Vet-Berkeley Study: New Therapy Holds Promise for Restoring Vision

Penn Vet-Berkeley Study: New Therapy Holds Promise for Restoring Vision

A new chemical-genetic therapy restores light responses to the retinas of blind mice and dogs and enables the mice to guide their behavior according to visual cues, setting the stage for clinical trial in humans.

Katherine Unger Baillie

Brain Activity after Smokers Quit Predicts Chances of Relapsing, Penn Medicine Study Suggests

Brain Activity after Smokers Quit Predicts Chances of Relapsing, Penn Medicine Study Suggests

Quitting smoking sets off a series of changes in the brain that Penn Medicine researchers say may better identify smokers who will start smoking again—a prediction that goes above and beyond today’s clinical or behavioral tools for assessing relapse risk.

Steve Graff

Penn Study Points to New Therapeutic Strategy in Chronic Kidney Disease

Penn Study Points to New Therapeutic Strategy in Chronic Kidney Disease

Chronic kidney disease (CKD) affects at least one in four Americans who are older than 60 and can significantly shorten lifespan. Yet the few available drugs for CKD can only modestly delay the disease’s progress towards kidney failure.

Karen Kreeger

Penn Medicine Team Develops Cognitive Test Battery to Assess the Impact of Long Duration Spaceflights on Astronauts’ Brain Function

Penn Medicine Team Develops Cognitive Test Battery to Assess the Impact of Long Duration Spaceflights on Astronauts’ Brain Function

Space is one of the most demanding and unforgiving environments. Human exploration of space requires astronauts to maintain consistently high levels of cognitive performance to ensure mission safety and success, and prevent potential errors and accidents.

Greg Richter